Calif. heart device firm completes $48 million funding round

03/1/2013 | American City Business Journals

CardioKinetix has raised $23 million in the second tranche of its Series E funding round, bringing the total for that round to $48 million. The funding will enable the company to advance its efforts to bring its Parachute ventricular partitioning system designed for heart failure patients to the global market, President and CEO Maria Sainz said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC